Ohio River Regional - AACE 20th Annual Meeting

Indianapolis, IN US
July 27, 2018 to July 28, 2018

Welcome, and thank you for attending the Ohio River Regional Chapter of the American Association of Clinical Endocrinologists 
20th Annual Meeting.

The Ohio River Regional Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease. This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high-quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

http://syllabus.aace.com/2018/Chapters/Ohio_River_Regional/index.html

Target Audience

Endocrinologists, endocrine surgeons, MD/DOs, advance practice clinicians, and other health care professionals living or working in Indiana, Kentucky, Ohio and Pennsylvania who practice, or are interested in, the treatment of endocrine disease states.

Learning Objectives

  1. Understand the cardiovascular outcomes of recent SGLT2 inhibitor outcome studies
  2. Review the differences between these studies
  3. Consider the implications of these studies in patient care
  4. Understand a need for better biomarkers to predict development of T1D
  5. Identify proinsulin C-peptide ratios as a potential biomarker of beta cell stress in T1D
  6. Review the literature on the prevalence and impact of depression in adults with type 1 and type 2 diabetes.
  7. Review the literature on screening for depression in adults with type 1 and type 2 diabetes.
  8. Review the literature on empirically validated interventions for depression in adults with diabetes.
  9. Understand medical features of new insulins
  10. Understand market features of new insulins
  11. Understand practical uses of new insulins
  12. Understand various macronutrients in a diet
  13. Understand the effects of macronutrients on glycemic excursion in a patient with diabetes
  14. Understand the need for further research to develop insulin dosing for fat and protein
  15. Recognize chronic opioid therapy as known risk for developing central adrenal insufficiency
  16. Recognize induction of vasculitis from injectable diabetic medications
  17. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  18. Articulate the change in understanding regarding the underlying explanation for transgender identity
  19. Outline transgender hormone strategies
  20. Consider transgender hormone monitoring strategies
  21. Identify the pituitary disorders associated with infertility
  22. Understand how to manage functioning pituitary tumors in patients who seek fertility
  23. Understand how to manage nonfunctioning tumors and hypopituitarism in patients who desire fertility
  24. Describe the clinical features and pathophysiology of hypophosphatemic rickets
  25. Discuss the clinical diagnosis of hypophosphatemic rickets
  26. Discuss medical management of X-linked hypophosphatemic rickets
  27. Understand the interpretation of thyroid function tests in pregnant women
  28. Diagnose and treat hypothyroidism in pregnancy
  29. Diagnose and treat hyperthyroidism in pregnancy
  30. Describe the evaluation and management of irregular periods and amenorrhea in a range of ovarian diagnoses including PCOS, premature ovarian insufficiency, ovarian failure, natural/surgical menopause and hypothalamic amenorrhea
  31. Update on treatment options for dermatologic and metabolic complications of PCOS and hyperandrogenism
  32. Recommend basic work up and outline treatment options for fertility in women with PCOS and special considerations in women with other forms of hyperandrogenism such as NCCAH and CAH
  33. Understand the clinical presentation of lipodystrophy syndromes
  34. Understand the steps that need to be taken to reach the clinical diagnosis of lipodystrophy
  35. Understand the current treatment options as well as treatments in development for lipodystrophy
  36. Describe how food and diet shapes the microbiome
  37. Describe how diet and the microbiome shapes health
  38. Understand that the microbiome is established in infancy and early childhood
  39. Define non-nutritive-sweetened beverages and their characteristics
  40. Describe mechanisms through which non-nutritive-sweetened beverages may impact body weight and glycemic control
  41. Summarize the human experimental evidence on the impact of non-nutritive-sweetened beverages on obesity, diabetes, and cardiovascular disease
  42. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Nutrition
Obesity
Pituitary
Reproductive
Thyroid
Course summary
Available credit: 
  • 9.50 AMA
  • 9.50 Attendance
Course opens: 
07/27/2018
Course expires: 
07/28/2019
Event starts: 
07/27/2018 - 6:00pm
Event ends: 
07/28/2018 - 9:00pm
Cost:
$0.00

 

HYATT REGENCY INDIANAPOLIS
1 S CAPITOL AVE
INDIANAPOLIS, IN 46204

FRIDAY, JULY 27, 2018

6:00 – 7:00 PM

Hot Topics in Diabetes

6:00 – 6:15 PM

SGLT-2 Inhibition and Cardiovascular Disease
Robert Zimmerman, MD, FACE
Objectives

  1. Understand the cardiovascular outcomes of recent SGLT2 inhibitor outcome studies
  2. Review the differences between these studies
  3. Consider the implications of these studies in patient care
6:15 – 6:30 PM

Identifying Biomarkers That Can Predict the Development of T1D
Emily Sims, MD
Objectives

  1. Understand a need for better biomarkers to predict development of T1D
  2. Identify proinsulin C-peptide ratios as a potential biomarker of beta cell stress in T1D
6:30 – 6:45 PM

Diabetes and Depression: What every clinician needs to know
Mary de Groot, PhD
Objectives

  1. Review the literature on the prevalence and impact of depression in adults with type 1 and type 2 diabetes.
  2. Review the literature on screening for depression in adults with type 1 and type 2 diabetes.
  3. Review the literature on empirically validated interventions for depression in adults with diabetes.
6:45 – 7:00 PM

New Insulins
Kathleen Wyne, MD, PhD, FNLA, FACE
Objectives

  1. Understand medical features of new insulins
  2. Understand market features of new insulins
  3. Understand practical uses of new insulins
7:00 – 7:30 PM

Break / Buffet Dinner

7:30 – 8:30 PM

Oral Abstract Presentations

7:30 – 7:50 PM

Do Fat and Protein Affect Post Prandial Glycemia in the Outpatient Real World Setting?
Neha Verma, MD
Objectives

  1. Understand various macronutrients in a diet
  2. Understand the effects of macronutrients on glycemic excursion in a patient with diabetes
  3. Understand the need for further research to develop insulin dosing for fat and protein
7:50 – 8:10 PM

Current Knowledge and Practices of Health Care Professionals on Opioids-Induced Adrenal Insufficiency
Zeb Saeed, MBBS
Objectives

  1. Recognize chronic opioid therapy as known risk for developing central adrenal insufficiency
8:10 – 8:30 PM

Suspected Induction of Vasculitis in Antiphospholipid Antibody Positive Patient by Injectable Diabetic Medications
Margo Simon, DO
Objectives

  1. Recognize induction of vasculitis from injectable diabetic medications
8:30 – 9:15 PM

Welcome Reception

SATURDAY, JULY 28, 2018

7:00 – 7:45 AM

Registration & Breakfast

7:45 – 8:15 AM

Welcome & Pre-Meeting Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:15 – 8:55 AM

Transgender Medicine
Josh Safer, MD, FACP
Objectives

  1. Articulate the change in understanding regarding the underlying explanation for transgender identity
  2. Outline transgender hormone strategies
  3. Consider transgender hormone monitoring strategies
8:55 – 9:05 AM

Q & A

9:05 – 9:45 AM

Pituitary Causes of Infertility
Lisa Nachtigall, MD
Objectives

  1. Identify the pituitary disorders associated with infertility
  2. Understand how to manage functioning pituitary tumors in patients who seek fertility
  3. Understand how to manage nonfunctioning tumors and hypopituitarism in patients who desire fertility
9:45 – 9:55 AM

Q & A

9:55 – 10:30 AM

Break

10:30 – 11:10 AM

X-linked Hypophosphatemic Rickets Across the Lifespan
Erik Imel, MD
Objectives

  1. Describe the clinical features and pathophysiology of hypophosphatemic rickets
  2. Discuss the clinical diagnosis of hypophosphatemic rickets
  3. Discuss medical management of X-linked hypophosphatemic rickets
11:10 – 11:20 AM

Q & A

11:20 – 12:00 PM

Thyroid & Pregnancy
Elizabeth Pearce, MD, FACE
Objectives

  1. Understand the interpretation of thyroid function tests in pregnant women
  2. Diagnose and treat hypothyroidism in pregnancy
  3. Diagnose and treat hyperthyroidism in pregnancy
12:00 – 12:10 PM

Q & A

12:10 – 1:10 PM

Lunch

12:20 – 1:00 PM

Business Meeting, Advocacy update, Abstract awards, Coding update

1:10 – 1:50 PM

Reproductive Endocrinology in Daily Clinical Practice
Jennifer Glueck, MD
Objectives

  1. Describe the evaluation and management of irregular periods and amenorrhea in a range of ovarian diagnoses including PCOS, premature ovarian insufficiency, ovarian failure, natural/surgical menopause and hypothalamic amenorrhea
  2. Update on treatment options for dermatologic and metabolic complications of PCOS and hyperandrogenism
  3. Recommend basic work up and outline treatment options for fertility in women with PCOS and special considerations in women with other forms of hyperandrogenism such as NCCAH and CAH
1:50 – 2:00 PM

Q & A

2:00 – 2:40 PM

Lipodystrophy Syndromes: Diagnosis and treatment
Elif A. Oral, MD
Objectives

  1. Understand the clinical presentation of lipodystrophy syndromes
  2. Understand the steps that need to be taken to reach the clinical diagnosis of lipodystrophy
  3. Understand the current treatment options as well as treatments in development for lipodystrophy
2:40 – 2:50 PM

Q & A

2:50 – 3:20 PM

Break

3:20 – 4:00 PM

At the Nexus of Food, the Microbiome, and Health
Carolyn Slupsky, PhD
Objectives

  1. Describe how food and diet shapes the microbiome
  2. Describe how diet and the microbiome shapes health
  3. Understand that the microbiome is established in infancy and early childhood
4:00 – 4:10 PM

Q & A

4:10 – 4:50 PM

Non-Nutritive-Sweetened Beverages, Obesity, and Diabetes: Efficacy or harm?
Mark Pereira, PhD
Objectives

  1. Define non-nutritive-sweetened beverages and their characteristics
  2. Describe mechanisms through which non-nutritive-sweetened beverages may impact body weight and glycemic control
  3. Summarize the human experimental evidence on the impact of non-nutritive-sweetened beverages on obesity, diabetes, and cardiovascular disease
4:50 – 5:00 PM

Q & A

5:00 – 5:15 PM

Post Meeting Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
5:15 PM

Adjourn

Hyatt Regency Indianapolis
1 S Capitol Ave
Indianapolis, IN 46204
United States

Mary de Groot, PhD
Associate Professor
Acting Director
Diabetes Translational Research Center
Indiana University School of Medicine
Indianapolis, IN

Jennifer Glueck, MD
Assistant Professor of Medicine
Rush University Medical Center
Chicago, IL
Reproductive and Endocrine Health
Highland Park, IL

Erik Allen Imel, MD
Associate Professor of Medicine and Pediatrics
Division of Endocrinology and Metabolism
Department of Internal Medicine
Pediatric Endocrinology/Diabetology Section
Department of Pediatrics
Indiana University School of Medicine
Indiana Center for Musculoskeletal Health
Indianapolis, IN

Lisa B. Nachtigall, MD
Associate Professor of Medicine
Harvard Medical School
Clinical co-director Neuroendocrine Clinical Center
Massachusetts General Hospital
Boston, MA

Elif Arioglu Oral, MD
Associate Professor
Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND)
University of Michigan
Ann Arbor, MI

Elizabeth N. Pearce, MD, MSc, FACE
Associate Professor of Medicine
Boston University School of Medicine
Boston, MA

Mark A. Pereira, PhD
Professor
Division of Epidemiology & Community Health
School of Public Health
University of Minnesota
Minnesota, MN

Zeb Saeed, MBBS
Endocrinology Fellow
Indiana University
School of Medicine
Indianapolis, IN

Joshua D. Safer, MD, FACP
Executive Director, Center for Transgender Medicine and Surgery
The Mount Sinai Hospital and the Icahn School of Medicine at Mount Sinai
New York, NY

Margo Simon, DO
Cleveland Clinic
Cleveland, OH

Emily K. Sims, MD
Assistant Professor of Pediatrics
Indiana University School of Medicine
Herman B Wells Center for Pediatric Research
Pediatric Endocrinology and Diabetology
Center for Diabetes and Metabolic Diseases
Indianapolis, IN

Carolyn Slupsky, PhD
Professor, Department of Nutrition and Department of Food Science & Technology
Chair, Graduate Group in Nutritional Biology
Kinsella Endowed Chair in Food, Nutrition, and Health
Chancellor's Fellow
University of California, Davis
Davis, CA

Neha Verma, MD
Endocrinology fellow, PGY-5
Ohio State University
Columbus, OH

*Kathleen Wyne, MD, PhD, FNLA, FACE
Director, Adult Type 1 Diabetes Program
Associate Professor of Clinical Medicine
Division of Diabetes, Endocrinology and Metabolism
The Ohio State University Wexner Medical Center
Columbus, OH

*Robert S. Zimmerman, MD, FACE
Vice Chairman Endocrinology
Director Cleveland Clinic Diabetes Center
Cleveland Clinic
Cleveland, OH

* Indicates both a member of the Program Committee and faculty.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Ohio River Regional Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 9.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 9.50 AMA
  • 9.50 Attendance

Accreditation Period

Course opens: 
07/27/2018
Course expires: 
07/28/2019

Price

Cost:
$0.00
Please login or register to take this course.